Premium Essay

Access the Innovation Capability in the Life and Health Sciences Sector

In: Business and Management

Submitted By mdoran1
Words 5612
Pages 23
Index

Page 1 – Index Page
Page 2 – Team Members Contribution
Page 3 – Introduction
Page 4 &5 – Profile (Part1)
Page 6&7-- Theory (Part 2)
Pages 8, 9, 10 & 11 – Change (Part 3)
Pages 12, 13, 14 & 15 – Opportunity (Part 4)
Page 16 – Conclusion
Pages 17, 18& 19 – Bibliography, References & Journals
Pages 20&21 – Log of Team Meetings
Pages 22-29 – Copy of PowerPoint Slides

Team Members Contribution

Introduction – *******
Part 1 – ******
Part 2 – *****
Part 3 – *****
Part 4 – *****
Conclusion – *****
References- ******
Bibliography – ******

Introduction

Innovation and entrepreneurship are generally regarded as critical activities for economic development, regeneration and growth both in the private and public sector.

The aim of our presentation is to access the innovation capability in the life and health sciences sector. We chose Norbrook laboratories as they are a worldwide international company and we felt they were a leading example.

Innovations& Entrepreneurship
Sector :Life& Health Sciences
Company Norbrook
Part One – Profile
Owner Lord bally Edmond Company
Name: Norbrook Laboratories Limited
Year Established: 1969
Norbrook is the largest privately owned pharmaceutical company in the world. Company Name: Norbrook Laboratories Limited ships product to 120 countries around the world has manufacturing plants in 4 continents.

“Since its foundation over 40 years ago, our company has grown to be one of the world’s leading pharmaceutical companies. Norbrook® Laboratories has established itself as a global leader in the development of revolutionary veterinary and animal health medicines. Norbrook® Laboratories Ltd is a dynamic and fast-growing international company, employing 1500 people in Newry and a further 1500 worldwide. We have a number of exciting opportunities from Sales &

Similar Documents

Premium Essay

State of Outsourcing

...The Knowledge Community HfS Research Collaborative Sourcing Intelligence& IT for Global Business Outsourcing Smart Governance Disruptive Technologies Insight. Advice. Benchmarking. Services State of the Outsourcing Industry 2013: Presentation to Genpact, March 5th 2013 Phil Fersht, Founder and CEO, HfS Research phil.fersht@hfsresearch.com Copyright © 2013 HfS Research Ltd. State of the industry 2013 - Agenda • Market Size and Forecast • Key Industry Dynamics • Competitive Landscape • Market Wrap Copyright © 2013 HfS Research Ltd. Outsourcing Smart Governance Disruptive Technologies 2 State of the industry 2013 - Intro • • • • • • Conducted December 2012 / January 2013 The largest-ever quantitative industry study covering both IT and business process outsourcing Respondents included 1355 stakeholders across enterprise buyers, service providers and consultant/influencer organizations The aim of the survey was to understand their views, observations and intentions for 2013 and beyond, when it comes to outsourcing IT and business processes Survey was conducted with the support of KPMG This presentation contains a set of slides with the top level results of the survey Copyright © 2013 HfS Research Ltd. Outsourcing Smart Governance Disruptive Technologies 3 Key Highlights: BPO Adoption and Outlook: • • • • • • • Deal activity rebounds Market forecasted to grow Attitudes towards BPO have gone “back to basics” Attitude of buyers...

Words: 2972 - Pages: 12

Premium Essay

Mfg. Trends in 2020

...Trends in manufacturing to 2020 A foresighting discussion paper Future Manufacturing Industry Innovation Council i Date: 30 September 2011 For more information, or to comment on the paper, please contact: Manager Future Manufacturing Department of Innovation, Industry, Science and Research GPO Box 9839 Canberra ACT 2601 Phone: (02) 6213 6000 Facsimile: (02) 6213 7000 Email: Futuremanufacturing@innovation.gov.au ii Future Manufacturing Council discussion paper: Trends in manufacturing to 2020 Table of Contents Executive summary ....................................................................................................................................1 Background.................................................................................................................................................2 Future Manufacturing Council................................................................................................................2 Defining manufacturing...........................................................................................................................2 Profile of Australian manufacturing........................................................................................................4 Trends to 2020 ... and beyond: Issues and opportunities for Australian manufacturing...................12 Terms of trade driving value and volatility of the Australian dollar and structural changes in the economy – an upside...

Words: 14303 - Pages: 58

Premium Essay

Macro Economic Factors

...factors that drive the pharmaceutical industry with a brief insight into how these levers impact the key players and decisions in the sector. The report will also relate the key drivers of the industry to the pharmaceutical industry in Ireland and how it is facing these global challenges. Historically, the sector was dominated by large scale bulk compound manufacture but this has evolved into a diverse range of complex technologies and treatments. In order to elaborate/detail on how this influences the strategy of individual organisations, we will highlight some of the activities of Glaxo-Smithkline (GSK) and how this company has evolved to adapt to the dynamic nature...

Words: 2748 - Pages: 11

Free Essay

Cybersecurity

...Statement Access to information is crucial to economic growth. Information and communications technology offer a powerful tool that, if deployed equitably, can ensure citizens are empowered and Government can deliver services more effectively. Information is vital for the efficient delivery of public and private sector product and services that are responsive to the needs of citizens and businesses as well as capacity creation. For a variety of reasons (economic and policy), developing countries like Kenya are less equipped to take advantage of the potential in ICT to stimulate growth, and are likely to fall behind advanced economies. The Kenya ICT Master Plan is therefore not designed in isolation, given that there is evidence from developed countries that investment in ICT facilitates economic growth by increasing productivity. As the Kenya Government ensures an enabling ICT environment and regulatory framework, this plan aims at stimulating the setup of ICT-related businesses to enhance employment creation. At the heart of this document is a strategic intent to develop a robust ICT sector that will enhance economic growth through creation of businesses and hence employment. In the execution of this plan, Kenya will become a leading ICT hub for the region, improve the lives of her citizens and see significant ICT-led economic growth in line with Vision 2030. This ICT Master Plan aims at building and promoting an environment where more service sector businesses are...

Words: 4766 - Pages: 20

Free Essay

An Analysis of Order Qualifiers and Order Winners of the Operational Strategy of Pfizer Inc.

...Winners 6 4.0.1 Safe clinical trials and drug delivery methods to objects 6 4.0.2 Health and safety standards 7 4.0.3 License to manufacture 7 4.0.4 Off license manufacturing 7 4.0.5 License to distribute the products in a specific regions 7 4.0.6 Quality of products 7 4.0.7 Cost 8 4.0.8 Supply chain 8 4.0.9 Capacity 8 4.0.10 Innovation 8 4.0.11 Market offering 9 4.0.12 Human resources 9 4.0 Pfizer’s broad order winners and operational strategy 9 4.1.13 Improving the Performance of the Innovative Core 9 4.1.14 Engine for Sustainable Innovation 10 4.1.15 Making the Right Capital Allocation Decisions 14 4.1.16 Earning Respect from Society 15 4.1.17 Creating an Ownership Culture 16 4.1.18 Corporate Governance 17 5.0 Conclusion 17 6.0 References 18 1.0 Executive Summary This report investigates the operational strategy of Pfizer, world’s leading pharmaceutical company in terms of their order qualifiers and order winners. The objective of this work is to: * Evaluate the order qualifiers and the specific order winners in the pharmaceutical industry sector. * Evaluate how these order winners are met by Pfizer by giving evidence of their business model and operations...

Words: 3580 - Pages: 15

Premium Essay

Biocon

...2012 STRATEGIC MANAGEMENT TERM PAPER ALOK KEJARIWAL 1PI11MBA13 INTRODUCTION Industry Biotechnology Founded 1978 Founder(s) Kiran Mazumdar-Shaw Headquarters Bangalore, India Biocon Limited (BSE: 532523) is a global biopharmaceutical company with products and research services ranging from pre-clinical to clinical development through to commercialization.[ref 1] Within biopharmaceuticals, the Company manufactures generic active pharmaceutical ingredients (APIs) like Statins and Immunosuppressants that are sold in the developed markets of the United States and Europe. It also manufactures biosimilar Insulins, which are sold in India as branded formulations and in both bulk and formulation forms. Located with R & D in Bangalore and API unit in Hyderabad, India, Biocon has two subsidiaries— Syngene, a custom research organization, and Clinigene, a clinical research organization. Biocon’s presence straddles four main therapeutic areas—Diabetology, Cardiology, Nephrology and Oncology. History Biocon is a fully integrated healthcare company that delivers innovative biopharmaceutical solutions. November 29, 1978 Biocon India is incorporated as a joint venture between Biocon Biochemicals Ltd. of Ireland and an Indian entrepreneur, Kiran Mazumdar-Shaw. 1979—Becomes the first Indian company to manufacture and export enzymes to USA and Europe. 1989—Unilever plc. acquires Biocon Biochemicals Ltd. in Ireland and merges it with...

Words: 4668 - Pages: 19

Premium Essay

Oil and Gas

...Turn risks and opportunities into results Exploring the top 10 risks and opportunities for global organizations Oil and gas sector Contents Introduction Executive summary Part 1: Risks Ernst & Young sector risk radar The top 10 risks 1. Access to reserves: political constraints and competition for proven reserves 2. Uncertain energy policy 3. Cost containment 4. Worsening fiscal terms 5. Health, safety and environmental risks 6. Human capital deficit 7. New operational challenges, including unfamiliar environments 8. Climate change concerns 9. Price volatility 10. Competition from new technologies 1 3 6 7 8 8 10 12 14 16 18 20 21 22 23 24 25 26 26 28 29 30 32 34 36 38 39 40 42 Part 2: Opportunities Ernst & Young opportunity ladder The top 10 opportunities 1. Frontier acreage 2. Unconventional sources 3. Conventional reserves in challenging areas 4. Rising emerging market demand 5. NOC-IOC partnerships 6. Investing in innovation and R&D 7. Alternative fuels, including second generation biofuels 8. Cross-sector strategic partnerships 9. Building regulatory confidence 10. Acquisitions or alliances to gain new capabilities Methodology Introduction While risk continues to dominate the business agenda, competition is also becoming just as dominant a feature. Market volatility, pricing pressure, variations in market performance, demanding stakeholders — all have contributed to a global economy that encourages competitive drive. And with that drive comes...

Words: 17439 - Pages: 70

Premium Essay

Finanve in Banking

...Strategic Management Biocon – Term Paper Name: Naresh.N Section: B Semester : 3rd Batch : 2011-2013 PES Institute of Technology 2012 1/1/2012 INTRODUCTION Industry Biotechnology Founded 1978 Founder(s) Kiran Mazumdar-Shaw Headquarters Bangalore, India Biocon Limited (BSE: 532523) is a global biopharmaceutical company with products and research services ranging from pre-clinical to clinical development through to commercialization.[ref 1] Within biopharmaceuticals, the Company manufactures generic active pharmaceutical ingredients (APIs) like Statins and Immunosuppressants that are sold in the developed markets of the United States and Europe. It also manufactures biosimilar Insulins, which are sold in India as branded formulations and in both bulk and formulation forms. Located with R & D in Bangalore and API unit in Hyderabad, India, Biocon has two subsidiaries— Syngene, a custom research organization, and Clinigene, a clinical research organization. Biocon’s presence straddles four main therapeutic areas—Diabetology, Cardiology, Nephrology and Oncology. History Biocon is a fully integrated healthcare company that delivers innovative biopharmaceutical solutions. November 29, 1978 Biocon India is incorporated as a joint venture between Biocon Biochemicals Ltd. of Ireland and an Indian entrepreneur, Kiran Mazumdar-Shaw. 1979—Becomes the first Indian company to manufacture and export enzymes to...

Words: 4681 - Pages: 19

Premium Essay

Marx

...5 The Global Innovation Divide Jeffrey Sachs, The Earth Institute at Columbia University, and NBER Executive Summary Until very recently, science was not considered a core part of development strategy, especially in the case of the poorest countries. While this misconception is changing, as it changes, it is becoming clear that there is not enough of the critically needed science base to solve a lot of the development problems in the poorest countries. This chapter highlights the causes of this divide as well as steps that can be taken to promote a technological upgrading in lowincome countries, whether by the diffusion of technologies from abroad, or by the development of innovative technologies at home. I. Introduction My subject here is the nature of innovation systems in poor countries or, more particularly, the lack of such systems, and why innovation and technological advance do not take place at a vigorous rate in large parts of the developing world. I'm going to identify some hypotheses and research issues to be pursued, very much hoping that the research group at the NBER can take on some of the challenges. I think that the challenges of economic development are not going to be addressed properly until we better integrate issues of science and technology into the basic economic development strategies of low-income countries. Until very recently, science was not considered a core part of development strategy, especially in the case of the poorest...

Words: 4149 - Pages: 17

Free Essay

Egovernment Strategies the Case of Uae

...eGovernment Strategies The Case of the United Arab Emirates (UAE) This article provides an overview of eGovernment and its role in revolutionising existing governmental systems. It argues that in order for eGovernment initiatives to truly succeed, we need to develop public trust and confidence to promote diffusion and participation. The article relates this to the recently announced UAE eGovernment Strategic Framework 2011-2013. The framework attempts to promote the electronic transformation of all government services within a period of three years. An important component of the strategic framework in question is the use of the existing national identity management infrastructure and the development of a government-owned federated identity management system to support Governmentto-Citizen (G2C) eGovernment transactions and promote trust and confidence on the Internet. Dr. Ali M. Al-Khouri United Arab Emirates Keywords eGovernment, identity management, federated identity, identity card. Government-owned identity management systems that provide secure, unique and tamper-proof digital identities should become a primary component of national eGovernment strategies. Such federated identity systems can gain higher levels of trust, confidence and encourage public participation and has the potential to enable new levels of collaboration between different government agencies. European Journal of ePractice · www.epracticejournal.eu Nº 17 · September 2012 · ISSN: 1988-625X ...

Words: 6736 - Pages: 27

Free Essay

Medical Technology

...Spotlight The Benefit of Expansion into Medical Technology financial crisis 2008 2009 2010 2011 Segment comparison at Agilent 2008 - 2011, in US$ M. Source: Agilent annual reports, Novumed Life Science Consulting In 1999, several business units were spun off from global computer technology provider HewlettPackard to form Agilent, with approx. US$ 8 billion in revenues. This spin-off marked the largest initial public offering in the history of Silicon Valley. Initially, Agilent’s revenues came predominantly from the sales of its electronic test & measurement and semiconductor business units. With its strong ties to the communication industry, specifically the internet, Agilent’s stock was valued highly. Despite this high regard, management decided not to focus solely on its core sectors, by creating a life sciences business unit in 2000. A wise decision in retrospect. The life sciences and chemical analysis units now collectively generate half of the company’s sales, and allowed Agilent to remain profitable despite the collapse of the electronic measurement unit’s profits during the financial crisis.  As one of many examples, this illustrates the growing importance of the medtech segment, which is gaining attention of industry groups from various sectors. What factors make medical technology so attractive? Which industries can benefit from expansion into this segment? DEFINITION Segmentation Medical technology is a widely used term but definitions...

Words: 3838 - Pages: 16

Free Essay

Title

...Center for US Health System Reform Business Technology Office The ‘big data’ revolution in healthcare Accelerating value and innovation January 2013 Peter Groves Basel Kayyali David Knott Steve Van Kuiken Contents The ‘big data’revolution in healthcare: Accelerating value and innovation 1 Introduction1 Reaching the tipping point: A new view of big data in the healthcare industry  2 Impact of big data on the healthcare system 6 Big data as a source of innovation in healthcare 10 How to sustain the momentum 13 Getting started: Thoughts for senior leaders 17 1 The ‘big data’ revolution in healthcare: Accelerating value and innovation Introduction An era of open information in healthcare is now under way. We have already experienced a decade of progress in digitizing medical records, as pharmaceutical companies and other organizations aggregate years of research and development data in electronic databases. The federal government and other public stakeholders have also accelerated the move toward transparency by making decades of stored data usable, searchable, and actionable by the healthcare sector as a whole. Together, these increases in data liquidity have brought the industry to the tipping point. Healthcare stakeholders now have access to promising new threads of knowledge. This information is a form of “big data,” so called not only for its sheer volume but for its complexity, diversity, and timeliness...

Words: 9757 - Pages: 40

Premium Essay

Role of Government in Promoting Innovation

...Innovation and Change | The role of governments in promoting innovation | | | | Gitanjali Khadagade- c7094037 | 5/14/2013 | | Table of Contents 1. Abstract ........................................................................................................3 2. Introduction to innovation ....................................................................3 3. Benefits of innovation to businesses ..................................................5 4. Why should government support innovation? ..............................6 5. National Innovation Systems ................................................................8 6.1. Role of the Government ...............................................................9 6.2. Innovation Policies .....................................................................10 6.3. Aim of Innovation Policies .......................................................10 6.4.1. National Innovation System of Europe ..........................10 6.4.2. Government of UL ..................................................................11 6.4.3. Government of India .............................................................11 6.4.4. Government of Finland .........................................................12 6.4.5. Government of China .............................................................13 6. Observations and Conclusions ..........

Words: 3783 - Pages: 16

Premium Essay

Orthogonal Matrices

...Kku iëëÞ eÛk«Ú ¾HœÈä¢ Oã]¶ sÐ_ :±ò Kku Knowledge Kkue~ e~ Kkue~ Kku ‹≈‰’≈∆ :±ò º°æfi»¢ :±ò Kku iëëÞ eÛk«Ú ¾HœÈä¢ Oã]¶ sÐ_ :±ò Kku Knowledge Kkue~ ‹≈‰’≈∆ :±ò º°æfi»¢ :±ò Kku iëëÞ eÛk«Ú ¾HœÈä¢ Oã]¶ sÐ_ :±ò Kku Knowledge Kkue~ Kkue~ Kku ‹≈‰’≈∆ :±ò º°æfi»¢ :±ò Kku iëëÞ eÛk«Ú ¾HœÈä¢ Oã]¶ sÐ_ :±ò Kku Knowledge Kkue~ ¢ Kkue~ Kku ‹≈‰’≈∆ :±ò º°æfi»¢ :±ò Kku iëëÞ eÛk«Ú ¾HœÈä¢ Oã]¶ sÐ_ :±ò Kku Knowledge Kkue~ Kkue~ Kku ‹≈‰’≈∆ :±ò º°æfi»¢ :±ò Kku iëëÞ eÛk«Ú ¾HœÈä¢ Oã]¶ sÐ_ :±ò Kku Knowledge Kkue~ Kkue~ Kku ‹≈‰’≈∆ :±ò º°æfi»¢ :±ò Kku iëëÞ eÛk«Ú ¾HœÈä¢ Oã]¶ sÐ_ ¢ Knowledge Kkue~ Kku Kkue~ Kku ‹≈‰’≈∆ :±ò º°æfi»¢ :±ò Kku iëëÞ eÛk«Ú ¾HœÈä¢ Oã]¶ sÐ_ :±ò Kku Knowledge Kkue~ Kkue~ Kku ‹≈‰’≈∆ :±ò º°æ ∆ :±ò Kku iëëÞ eÛk«Ú ¾HœÈä¢ Oã]¶ sÐ_ :±ò Kku Knowledge Kkue~ Kkue~ Kku ‹≈‰’≈∆ :±ò º°æfi»¢ :±ò Kku iëëÞ eÛk«Ú ¾HœÈä¢ Oã]¶ sÐ_ :±ò Kku Knowledge K u Kkue~ Kku ‹≈‰’≈∆ :±ò º°æfi»¢ :±ò Kku iëëÞ eÛk«Ú ¾HœÈä¢ Oã]¶ sÐ_ :±ò Kku Knowledge Kkue~ Kkue~ Kku ‹≈‰’≈∆ :±ò º°æfi»¢ :±ò Kku iëëÞ eÛk«Ú ¾Hœ O Oã]¶ sÐ_ :±ò Kku Knowledge Kkue~~ u Kkue~~ Kku ‹≈‰’≈∆ :±ò º°æfi»¢ :±ò Kku iëëÞ eÛkk«Ú ¾HHœÈä¢ Oã]¶ sÐ_ :±ò Kku Knowledge Kkue~~ O Kkue~~ Kku g g ‹≈‰’≈∆ :±ò º°æfi»¢ :±ò Kku iëëÞ eÛk«Ú ¾HœÈä¢ Oã]¶ sÐ_ :±ò Kku Knowledge Kkue~ O O e~ Kkue~ Kku ‹≈‰’≈∆ :±ò º°æfi»¢ :±ò Kku iëëÞ eÛk«Ú ¾HœÈä¢ Oã]¶ sÐ_ _ Knowledge Kkue~ Kku Kkue~ Kku ‹≈‰’≈∆ :±ò º°æfi»¢ :±ò Kku iëëÞ eÛk«Ú ¾HœÈä¢ Oã]¶ sÐ_ :±ò Kku Knowledge Kkue~ O Kkue~ Kku ‹≈‰’≈∆ :±ò º°æ fi» :±ò Kku iëëÞ eÛk«Ú ¾HHœÈä¢ Oã]¶ sÐ_ :±ò Kku Knowledge Kkue~ O Kkue~ Kku ‹≈‰’≈∆ :±ò º°æfi»¢...

Words: 32271 - Pages: 130

Premium Essay

Developent

...needs to do in order to achieve both economic growth and economic development before drawing to a conclusion DEFINITIONS Development: Development according to Todaro (2003,16) “must be conceived of as a multidimensional process involving major changes in social structures, popular attitudes, and national institutions, as well as the acceleration of economic growth, the reduction of inequality, and the eradication of poverty”. He further went on to explain that development, in its essence, must represent the whole range of change by which an entire social system, tuned to the diverse basic needs and evolving aspirations of individuals and social groups within that system, moves away from a condition of life widely perceived as unsatisfactory toward a situation or condition of life regarded as materially and spiritually better. With regards to the above it, is prudent to add that people and social structures should move from their current situations to better ones then you can safely say development has taken place. Economic Growth: According to Schumpeter (1934) economic growth means more output, and changes in the technical and institutional arrangements by which it is produced. Economic growth also entails...

Words: 3517 - Pages: 15